Inter‐rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients
Background The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus. Objective To validate the accuracy and inter‐rater reliability (IRR) of the BIOCHIP i...
Saved in:
Published in | Journal of the European Academy of Dermatology and Venereology Vol. 33; no. 12; pp. 2327 - 2333 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.12.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0926-9959 1468-3083 1468-3083 |
DOI | 10.1111/jdv.15817 |
Cover
Abstract | Background
The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus.
Objective
To validate the accuracy and inter‐rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV).
Methods
Sera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1–5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de‐identified. Fleiss Kappa was used to estimate the IRR.
Results
Fleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt‐Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter‐rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001).
Conclusion
The BIOCHIP mosaic‐based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results. |
---|---|
AbstractList | The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus.
To validate the accuracy and inter-rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV).
Sera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1-5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de-identified. Fleiss Kappa was used to estimate the IRR.
Fleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt-Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter-rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001).
The BIOCHIP mosaic-based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results. The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus.BACKGROUNDThe BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus.To validate the accuracy and inter-rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV).OBJECTIVETo validate the accuracy and inter-rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV).Sera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1-5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de-identified. Fleiss Kappa was used to estimate the IRR.METHODSSera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1-5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de-identified. Fleiss Kappa was used to estimate the IRR.Fleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt-Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter-rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001).RESULTSFleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt-Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter-rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001).The BIOCHIP mosaic-based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results.CONCLUSIONThe BIOCHIP mosaic-based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results. Background The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus. Objective To validate the accuracy and inter‐rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV). Methods Sera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1–5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de‐identified. Fleiss Kappa was used to estimate the IRR. Results Fleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt‐Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter‐rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001). Conclusion The BIOCHIP mosaic‐based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results. |
Author | Hashimoto, T. Yamagami, J. Di Zenzo, G. Uzun, S. Vassileva, S. Melbourne, W. Daneshpazhooh, M. Mascaro, J.M. Patsatsi, A. Xuan, R.R. Mahmoudi, H. Drenovska, K. Yang, A. Murrell, D.F. |
Author_xml | – sequence: 1 givenname: A. orcidid: 0000-0002-9184-5484 surname: Yang fullname: Yang, A. organization: St George Hospital – sequence: 2 givenname: R.R. orcidid: 0000-0001-6893-4422 surname: Xuan fullname: Xuan, R.R. organization: University of New South Wales – sequence: 3 givenname: W. surname: Melbourne fullname: Melbourne, W. organization: St George Hospital – sequence: 4 givenname: T. surname: Hashimoto fullname: Hashimoto, T. organization: Osaka City University Graduate School of Medicine – sequence: 5 givenname: S. surname: Uzun fullname: Uzun, S. organization: Akdeniz University School of Medicine – sequence: 6 givenname: M. orcidid: 0000-0003-1020-8895 surname: Daneshpazhooh fullname: Daneshpazhooh, M. organization: Tehran University of Medical Sciences – sequence: 7 givenname: J. surname: Yamagami fullname: Yamagami, J. organization: Keio University School of Medicine – sequence: 8 givenname: G. surname: Di Zenzo fullname: Di Zenzo, G. organization: IDI‐IRCCS – sequence: 9 givenname: J.M. surname: Mascaro fullname: Mascaro, J.M. organization: Hospital Clinic and Barcelona University Medical School – sequence: 10 givenname: H. orcidid: 0000-0002-1890-1005 surname: Mahmoudi fullname: Mahmoudi, H. organization: Tehran University of Medical Sciences – sequence: 11 givenname: A. orcidid: 0000-0001-9616-2001 surname: Patsatsi fullname: Patsatsi, A. organization: Aristotle University School of Medicine – sequence: 12 givenname: K. surname: Drenovska fullname: Drenovska, K. organization: Sofia University of Medicine – sequence: 13 givenname: S. surname: Vassileva fullname: Vassileva, S. organization: Sofia University of Medicine – sequence: 14 givenname: D.F. surname: Murrell fullname: Murrell, D.F. email: d.murrell@unsw.edu.au organization: St George Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31325388$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc9u1DAQxi3Uim4LB14A-QiHtHacOPERlj_dqlI5AFfLsSetK8debAe0Nw48AM_Ik-Dt7l4q8GVkze_7NDPfKTrywQNCLyg5p-Vd3Jvv57TtafcELWjD-4qRnh2hBRE1r4RoxQk6TemeEEIL9hSdMMrqlvX9Av1a-Qzxz8_fUZWKIzirButs3uAw4nwH-O3qZnm5-oStNzaCzthO0-zD6OYQIWnwGrCBOKkcXLjd4CkkZXXB8TA7F-aE1zCt7-xtsAYrbw7fbUNlCz6nZ-h4VC7B8309Q18-vP-8vKyubz6ulm-uK80E7SpQ9TByRfRATMug6bQyMKiRd2OjRMNYQ1rWCNULSgzVSnHCW1NO0RFt-rZjZ-jVzncdw7cZUpaTLRs4pzyUQWVdcyp4X_Mt-nKPzsMERq6jnVTcyMPlCnCxA3QMKUUYpba57BN8jso6SYncZiNLNvIhm6J4_UhxMP0Xu3f_YR1s_g_Kq3dfd4q_ZDChfg |
CitedBy_id | crossref_primary_10_1016_j_jaad_2020_11_076 crossref_primary_10_23736_S0392_0488_19_06517_9 crossref_primary_10_3389_fimmu_2023_1111172 crossref_primary_10_3390_brainsci13091286 crossref_primary_10_1007_s15011_021_4839_0 crossref_primary_10_3389_fimmu_2024_1426834 crossref_primary_10_1080_1744666X_2021_1945925 crossref_primary_10_1111_jdv_17087 |
Cites_doi | 10.1046/j.0022-202X.2003.22126.x 10.1037/0021-9010.93.5.959 10.1016/j.ijwd.2015.01.002 10.1007/s00403-016-1632-0 10.1016/0022-2496(66)90002-2 10.1046/j.1523-1747.1999.00632.x 10.1016/S0190-9622(99)70183-0 10.1111/j.1365-2230.2010.03845.x 10.1111/jdv.15770 10.1186/1750-1172-7-49 10.1037/h0031619 10.1111/j.1346-8138.2011.01382.x 10.1111/1523-1747.ep12616580 10.1016/S0140-6736(05)66829-8 10.1172/JCI113803 10.1159/000339776 10.1016/j.acthis.2013.12.012 10.1046/j.1365-2133.1999.02752.x 10.1037/h0031643 10.1111/j.1365-2133.2004.06082.x 10.2307/2529310 10.1016/j.autrev.2014.01.011 10.1016/j.det.2011.03.012 10.1016/S0923-1811(02)00109-3 |
ContentType | Journal Article |
Copyright | 2019 European Academy of Dermatology and Venereology 2019 European Academy of Dermatology and Venereology. |
Copyright_xml | – notice: 2019 European Academy of Dermatology and Venereology – notice: 2019 European Academy of Dermatology and Venereology. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/jdv.15817 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-3083 |
EndPage | 2333 |
ExternalDocumentID | 31325388 10_1111_jdv_15817 JDV15817 |
Genre | article Journal Article |
GroupedDBID | --- --K .3N .GA .Y3 05W 0R~ 10A 1B1 1OB 1OC 1~5 29L 31~ 33P 36B 3SF 4.4 4G. 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AAHQN AAIPD AALRI AAMNL AANHP AANLZ AAONW AAQFI AAQXK AASGY AAXRX AAXUO AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABQWH ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADZMN AE3 AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFTJW AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CO8 COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD ESX EX3 F00 F01 F04 F5P FDB FEDTE FGOYB FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 NF~ NQ- O66 O9- OIG OVD OZT P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K R2- RIG RIWAO RJQFR ROL RPZ RX1 SAMSI SEW SUPJJ TEORI UB1 UHS W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX ACVFH ADCNI AEUPX AEYWJ AFPUW AGHNM AGQPQ AGYGG AIGII CITATION CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c3917-ea2bf6a0cb0d53e47cadebaf67f4a9433405349a8910d1caa6065d08370cd8573 |
IEDL.DBID | DR2 |
ISSN | 0926-9959 1468-3083 |
IngestDate | Thu Jul 10 23:44:32 EDT 2025 Wed Feb 19 02:30:47 EST 2025 Thu Apr 24 23:03:37 EDT 2025 Tue Jul 01 04:12:01 EDT 2025 Wed Jan 22 16:36:43 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | 2019 European Academy of Dermatology and Venereology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3917-ea2bf6a0cb0d53e47cadebaf67f4a9433405349a8910d1caa6065d08370cd8573 |
Notes | None. Conflict of interest Funding source None declared. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9184-5484 0000-0002-1890-1005 0000-0001-9616-2001 0000-0003-1020-8895 0000-0001-6893-4422 |
PMID | 31325388 |
PQID | 2261968267 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2261968267 pubmed_primary_31325388 crossref_citationtrail_10_1111_jdv_15817 crossref_primary_10_1111_jdv_15817 wiley_primary_10_1111_jdv_15817_JDV15817 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2019 |
PublicationDateYYYYMMDD | 2019-12-01 |
PublicationDate_xml | – month: 12 year: 2019 text: December 2019 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of the European Academy of Dermatology and Venereology |
PublicationTitleAlternate | J Eur Acad Dermatol Venereol |
PublicationYear | 2019 |
References | 2015; 1 2004; 122 1966; 3 2014; 116 2002; 30 2016; 308 2017; 25 1999; 140 2012; 39 1999; 40 2011; 36 2012; 225 1992; 99 1995; 4 2008; 93 2015; 173 1971; 76 1977; 159–74 2005; 366 2004; 151 2019 2014; 13 1999; 113 1977; 33 2012; 7 1988; 82 2011; 29 2012; 21 e_1_2_6_10_1 e_1_2_6_30_1 Landis JR (e_1_2_6_18_1) 1977; 159 Van Beek N (e_1_2_6_23_1) 2012; 21 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_11_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_15_1 e_1_2_6_20_1 Ozkesici B (e_1_2_6_24_1) 2017; 25 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 Hashimoto T (e_1_2_6_16_1) 1995; 4 e_1_2_6_25_1 e_1_2_6_3_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_28_1 Chiang YZ (e_1_2_6_21_1) 2015; 173 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 25 start-page: 202 year: 2017 end-page: 209 article-title: The Value of the BIOCHIP mosaic‐based indirect immunofluorescence technique in the diagnosis of pemphigus and bullous pemphigoid In turkish patients publication-title: Acta Dermatovenerol Croat – volume: 1 start-page: 4 year: 2015 end-page: 12 article-title: Autoimmune blistering diseases in females: a review publication-title: Int J Womens Dermatol – volume: 3 start-page: 1 year: 1966 end-page: 18 article-title: The axioms and principal results of classical test theory publication-title: J Math Psychol – volume: 113 start-page: 22 year: 1999 end-page: 25 article-title: Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice publication-title: J Invest Dermatol – volume: 39 start-page: 141 year: 2012 end-page: 144 article-title: Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires publication-title: J Dermatol – volume: 36 start-page: 12 year: 2011 end-page: 18 article-title: Clinical and immunopathological evaluation of epidermolysis bullosa acquisita publication-title: Clin Exp Dermatol – volume: 40 start-page: 167 issue: 2 Pt 1 year: 1999 end-page: 170 article-title: The clinical phenotype of pemphigus is defined by the anti‐desmoglein autoantibody profile publication-title: J Am Acad Dermatol – volume: 366 start-page: 61 year: 2005 end-page: 73 article-title: Pemphigus publication-title: Lancet – volume: 159–74 year: 1977 article-title: The measurement of observer agreement for categorical data publication-title: Biometrics – volume: 29 start-page: 405 year: 2011 end-page: 412 article-title: Diagnosis and clinical features of pemphigus foliaceus publication-title: Dermatol Clin – volume: 173 start-page: 7 year: 2015 end-page: 8 article-title: Biochip immunofluorescence microscopy as a new diagnostic tool for autoimmune blistering skin diseases publication-title: Br J Dermatol – volume: 33 start-page: 159 year: 1977 end-page: 174 article-title: The measurement of observer agreement for categorical data publication-title: Biometrics – year: 2019 article-title: Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceous publication-title: J Eur Acad Dermatol Venereol – volume: 99 start-page: 243 year: 1992 end-page: 250 article-title: Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180 publication-title: J Invest Dermatol – volume: 76 start-page: 365 year: 1971 end-page: 377 article-title: Measures of response agreement for qualitative data: some generalizations and alternatives publication-title: Psychol Bull – volume: 93 start-page: 959 year: 2008 end-page: 981 article-title: Ill‐structured measurement designs in organizational research: implications for estimating interrater reliability publication-title: J Appl Psychol – volume: 4 start-page: 63 year: 1995 end-page: 69 article-title: Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1 publication-title: Epithelial Cell Biol – volume: 7 start-page: 49 year: 2012 article-title: Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic‐based indirect immunofluorescence technique with the conventional multi‐step single test strategy publication-title: Orphanet J Rare Dis – volume: 13 start-page: 477 year: 2014 end-page: 481 article-title: Diagnosis and classification of pemphigus and bullous pemphigoid publication-title: Autoimmun Rev – volume: 82 start-page: 1864 year: 1988 end-page: 1870 article-title: Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies publication-title: J Clin Invest – volume: 225 start-page: 37 year: 2012 end-page: 44 article-title: Anti‐skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases publication-title: Dermatology – volume: 30 start-page: 224 year: 2002 end-page: 232 article-title: BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid publication-title: J Dermatol Sci – volume: 140 start-page: 351 year: 1999 end-page: 357 article-title: Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus publication-title: Br J Dermatol – volume: 308 start-page: 273 year: 2016 end-page: 276 article-title: The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita publication-title: Arch Dermatol Res – volume: 21 start-page: e34 year: 2012 article-title: Prospective comparison of a specially composed biochip mosaic with the conventional multistep procedure in the serological diagnosis of autoimmune bullous diseases publication-title: Exp Dermatol – volume: 122 start-page: 103 year: 2004 end-page: 110 article-title: Characterization of the anti‐BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients publication-title: J Invest Dermatol – volume: 116 start-page: 713 year: 2014 end-page: 716 article-title: The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris publication-title: Acta Histochem – volume: 151 start-page: 126 year: 2004 end-page: 131 article-title: Evaluation of a BP180‐NC16a enzyme‐linked immunosorbent assay in the initial diagnosis of bullous pemphigoid publication-title: Br J Dermatol – volume: 76 start-page: 378 year: 1971 article-title: Measuring nominal scale agreement among many raters publication-title: Psychol Bull – ident: e_1_2_6_8_1 doi: 10.1046/j.0022-202X.2003.22126.x – ident: e_1_2_6_26_1 doi: 10.1037/0021-9010.93.5.959 – ident: e_1_2_6_3_1 doi: 10.1016/j.ijwd.2015.01.002 – volume: 4 start-page: 63 year: 1995 ident: e_1_2_6_16_1 article-title: Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1 publication-title: Epithelial Cell Biol – ident: e_1_2_6_30_1 doi: 10.1007/s00403-016-1632-0 – ident: e_1_2_6_25_1 doi: 10.1016/0022-2496(66)90002-2 – ident: e_1_2_6_14_1 doi: 10.1046/j.1523-1747.1999.00632.x – volume: 173 start-page: 7 year: 2015 ident: e_1_2_6_21_1 article-title: Biochip immunofluorescence microscopy as a new diagnostic tool for autoimmune blistering skin diseases publication-title: Br J Dermatol – ident: e_1_2_6_12_1 doi: 10.1016/S0190-9622(99)70183-0 – ident: e_1_2_6_29_1 doi: 10.1111/j.1365-2230.2010.03845.x – ident: e_1_2_6_4_1 doi: 10.1111/jdv.15770 – ident: e_1_2_6_22_1 doi: 10.1186/1750-1172-7-49 – ident: e_1_2_6_17_1 doi: 10.1037/h0031619 – volume: 159 year: 1977 ident: e_1_2_6_18_1 article-title: The measurement of observer agreement for categorical data publication-title: Biometrics – ident: e_1_2_6_2_1 doi: 10.1111/j.1346-8138.2011.01382.x – ident: e_1_2_6_6_1 doi: 10.1111/1523-1747.ep12616580 – ident: e_1_2_6_10_1 doi: 10.1016/S0140-6736(05)66829-8 – ident: e_1_2_6_5_1 doi: 10.1172/JCI113803 – ident: e_1_2_6_20_1 doi: 10.1159/000339776 – volume: 21 start-page: e34 year: 2012 ident: e_1_2_6_23_1 article-title: Prospective comparison of a specially composed biochip mosaic with the conventional multistep procedure in the serological diagnosis of autoimmune bullous diseases publication-title: Exp Dermatol – volume: 25 start-page: 202 year: 2017 ident: e_1_2_6_24_1 article-title: The Value of the BIOCHIP mosaic‐based indirect immunofluorescence technique in the diagnosis of pemphigus and bullous pemphigoid In turkish patients publication-title: Acta Dermatovenerol Croat – ident: e_1_2_6_19_1 doi: 10.1016/j.acthis.2013.12.012 – ident: e_1_2_6_11_1 doi: 10.1046/j.1365-2133.1999.02752.x – ident: e_1_2_6_27_1 doi: 10.1037/h0031643 – ident: e_1_2_6_9_1 doi: 10.1111/j.1365-2133.2004.06082.x – ident: e_1_2_6_28_1 doi: 10.2307/2529310 – ident: e_1_2_6_13_1 doi: 10.1016/j.autrev.2014.01.011 – ident: e_1_2_6_15_1 doi: 10.1016/j.det.2011.03.012 – ident: e_1_2_6_7_1 doi: 10.1016/S0923-1811(02)00109-3 |
SSID | ssj0001158 |
Score | 2.3094327 |
Snippet | Background
The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the... The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2327 |
SubjectTerms | Case-Control Studies Fluorescent Antibody Technique - methods Humans Observer Variation Pemphigoid, Bullous - diagnosis |
Title | Inter‐rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdv.15817 https://www.ncbi.nlm.nih.gov/pubmed/31325388 https://www.proquest.com/docview/2261968267 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8UwEA7iQby4L8-NKB689NG9KZ5ceQouiIoHoWSrPNRW3gbPkwd_gL_RX-JM2j53EG8tnaZpMpN8k8x8IWQ9EB56DZ4FWFVbvnRji_mYjaaE78Tac7WN2chHx2Hjwj-8Cq6GyGaVC1PwQwwW3NAyzHiNBs5F-6ORq17dCZiDmeSOFyJv_u7ZO3UUIB0zCsduaCGnVskqZKJ4qjc_z0XfAOZnvGomnP1xcl1VtYgzua13O6IuH7-wOP7zXybIWAlE6VahOZNkSGdTZOSo3GqfJs9mrfD16QW5JFq0BV8oKL37NE8pwEa6fXCy0zg4pbjrjeMmbWKuSZ7edfOWIYmSmioc-M0RuX16n7d5U4I4FeD35t02fdCgS82bvKkoz1R1iw8Kttf2DLnY3zvfaVjlkQ2W9MDxszR3RRpyWwpbBZ72IwzyFzwNo9TnoBKgGIHnx5wBSlGO5Bz8p0DZyMAjFQsib5YMZ3mm5wmNI64ZFyGTCpxAETMR2dplAYt9CaWJGtmoOi-RJZ85Hqtxlwz8GtVLTKvWyNpA9KEg8fhJaLXSgARMDPdNeKahMRIXvcwQ_DCQmStUY1AMMl_CnMGgNqaDfy8_Ody9NBcLfxddJKMA0OIifGaJDHdaXb0MIKgjVoy2vwEonAVQ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xkEov0Actj5a6FYdessrm6Ui9UArapSxFCCouKPIr1YolQftAglMP_AB-I7-kM06yvIqEuCXKxHHssf2NZ-YzwGoofbIafAexqnEC5SUODygbTcugmRjfMy5lI3d2otZBsHUYHk7AtzoXpuSHGG-40ciw8zUNcNqQvj3K9VmjGfJmPAnT1j9HkGjvhjwKsY6dhxMvcohVq-IVsnE89at3V6MHEPMuYrVLzuYcHNWVLSNNjhujoWyoi3s8js_9m1cwW2FRtlYqz2uYMPkbeNGpvO1v4dJuF17_vSI6iT7r4ydKVu9zVmQMkSP73v613mrvMnJ809TJupRuUmS9UdG3PFHKME1zvz0l95ydFAPRVSjOJNarGA3YqUF16v4pupqJXNe39KAkfB3Mw8Hmxv56y6lObXCUj7afY4Qns0i4Sro69E0QU5y_FFkUZ4FArUDdCP0gERyBim4qIdCECrVLJDxK8zD238FUXuRmAVgSC8OFjLjSaAfKhMvYNR4PeRIoLE0uwte691JVUZrTyRq9dGza6LPUtuoifBmLnpY8Hv8T-lyrQIqjjFwnIjfYGKlHhmaEphjKvC91Y1wMkV_issGxNraHHy8_3frx214sPV30E8y09jvb6XZ75-cyvES8lpTRNB9gatgfmY-IiYZyxar-P2zrCW4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BlVAv0CfPUlP10EtW2cRJHPVEgdUuryIEFYdKkV9BKyBZ7QOJnnroD-hv7C_pjJMspQ-p4pYoE8exxzPf2OPPAG8jFVLUEHqIVa3HdZB6gtNuNKN4O7VhYH3ajXx4FHfP-N55dD4D75u9MBU_xHTCjUaGs9c0wAcm_3WQm5tWOxLtZBYe8RjdJCGikzvuKIQ6zgynQewRqVZNK-TSeJpX7zujPxDmfcDqPE5nET43da0STS5bk7Fq6S-_0Tg-8GeewEKNRNlWpTpPYcYWz2D-sF5rfw7f3GThj6_fiUxiyIb4hYrT-5aVOUPcyD70Pm53e8eMlr3JcLI-bTYp86tJOXQsUdoyQ5bfnZF7y67LkexrFGcKA99yMmIDi8rUvyj7hsnCNLf0oKJ7Hb2As87u6XbXq89s8HSIkZ9nZaDyWPpa-SYKLU8oy1_JPE5yLlEnUDOikKdSIEwxbS0lBlCR8YmCRxsRJeFLmCvKwi4DSxNphVSx0AajQJUKlfg2EJFIucbS1Aq8azov0zWhOZ2rcZVNAxtzk7lWXYE3U9FBxeLxN6HNRgMyHGO0cCILi42RBRRmxhiIocxSpRrTYoj6Ep2GwNq4Dv53-dnezid3sfr_oq9h_ninkx30jvbX4DGCtbRKpVmHufFwYl8hIBqrDaf4PwFXnggd |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inter-rater+reliability+of+the+BIOCHIP+indirect+immunofluorescence+dermatology+mosaic+in+bullous+pemphigoid+and+pemphigus+patients&rft.jtitle=Journal+of+the+European+Academy+of+Dermatology+and+Venereology&rft.au=Yang%2C+A&rft.au=Xuan%2C+R+R&rft.au=Melbourne%2C+W&rft.au=Hashimoto%2C+T&rft.date=2019-12-01&rft.issn=1468-3083&rft.eissn=1468-3083&rft.volume=33&rft.issue=12&rft.spage=2327&rft_id=info:doi/10.1111%2Fjdv.15817&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0926-9959&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0926-9959&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0926-9959&client=summon |